Timor-Leste
Tuberculosis profile
Population  2012 1.1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.82 (0.36–1.5) 74 (33–132)
Mortality (HIV+TB only)        
Prevalence  (includes HIV+TB) 8.4 (3.8–15) 758 (342–1 335)
Incidence  (includes HIV+TB) 5.6 (4.6–6.6) 498 (409–596)
Incidence (HIV+TB only)        
Case detection, all forms (%) 69 (58–84)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 1 545 (41) Relapse 40 (82)
Smear-negative 1 823 (48) Treatment after failure 4 (8)
Smear-unknown / not done 0 (0) Treatment after default 5 (10)
Extrapulmonary 420 (11) Other    
Other 0 (0)      
Total new 3 788   Total retreatment 49  
           
Other (history unknown)          
Total new and relapse 3 828   Total cases notified 3 837  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.3 1.2 0.8
Age < 15 19 334 118
Laboratories 2012
Smear (per 100 000 population) 1.6
Culture (per 5 million population)  
Drug susceptibility testing (per 5 million population)  
Is second-line drug susceptibility testing available? No
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 91   Is rifampicin used
throughout treatment for
new patients?
No
New smear-negative/extrapulmonary    
Retreatment 77  
TB/HIV 2012 Number (%)
TB patients with known HIV status 766 (20)
HIV-positive TB patients 4 (<1)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 4 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.6–2.8) 16 (11–21)
MDR-TB cases among notified pulmonary
TB cases
74 (54–94) 8 (5–10)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB   3 (6%) 3
Laboratory-confirmed MDR-TB cases   3 3
Patients started on MDR-TB treatment     4
Financing TB control 2013
National TB programme budget (US$ millions) 1.7
% Funded domestically 7%
% Funded internationally 93%
% Unfunded 0%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-21 Data: www.who.int/tb/data